AKOUOS
Live / Registered — Registered (as of 12 Mar 2024)
What this means for you
Registered since 12 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90332952
- Registration number
- 7327850
- Mark type
- Stylized text
- Filed
- 20 Nov 2020
- Published for opposition
- 15 Jun 2021
- Registered
- 12 Mar 2024
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules both in the nature of pharmaceutical preparations for the treatment of genetically-related inner ear diseases and conditions causing hearing loss; gene therapy products to restore, improve and preserve hearing, namely, genetically engineered tissues for inner ear transplant purposes and drug delivery agents for use in the inner ear consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; gene therapy products, namely, biological preparations for the treatment of inner ear disorders and conditions; viral vectors, non-viral vectors and gene therapy vectors all for medical purposes, namely, therapeutic agents for delivering nucleic acid and other genetic material to nuclei of targeted cells in the human body, for use in gene therapy to treat inner ear disorders and conditions; biotechnological platform technology for gene delivery to biological cells, namely, biological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to restore, improve and preserve hearing; biotechnological platform technology for gene delivery to biological cells, namely, biological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to treat inner ear disorders and conditions
Owner
- Akouos, Inc., Boston, MA, US
- Akouos, Inc., Boston, MA, US
- Akouos, Inc., Boston, MA, US
Prosecution history
- 12 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Jan 2024 — USE AMENDMENT FILED
- 01 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 13 Sept 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Sept 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Sept 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Sept 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 13 Sept 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED